A non-invasive imaging technology uses opto-acoustic (OA/US) ultrasound paired with an AI-powered physician-decision support tool to provide more information on whether suspicious breast lesions are malignant or benign.
- Pain Points When Maintaining a Cleanroom
- Manufacturing Durable Diabetes Tech for the 21st Century
- Innovation in Patient Monitoring and Wearables
- More Layoffs Signal COVID-19 Testing Boom Is Over
- Increasing COVID Numbers in China Creates Uncertainty
- High-Quality (Level 4) PMCF Surveys: What Are They?